insights_auto
Bakit tumaas ang TAK 2.31%?
Tingnan ang Higit pang Detalyechevron_right
TAK:NYSE
Takeda Pharmaceutical Co Ltd
$19.45
arrow_upward
+2.31%(+0.44) 1D
$19.46
arrow_upward
+0.05% (+0.0100)bedtimePagkalipas ng oras ng trabaho
Sarado: Okt 15, 4:00:06 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa TAK...
Buksan
$19.58
Mataas
$19.89
Mababa
$19.45
Mkt. cap
63.26B
Avg. na dami
2.51M
Dami
4.20M
Dividend
3.24%
Bawat tatlong buwang dividend
$0.16
Petsa ng ex-dividend
Set 29, 2026
Mataas nang 52-wk
$19.89
Mababa nang 52-wk
$12.99
EPS
-$0.33
Beta
-0.06
Mga natitirang share
3.20B
Bilang ng mga empleyado
47K
Buksan
$19.58
Mataas
$19.89
Mababa
$19.45
Mkt. cap
63.26B
Avg. na dami
2.51M
Dami
4.20M
Dividend
3.24%
Bawat tatlong buwang dividend
$0.16
Petsa ng ex-dividend
Set 29, 2026
Mataas nang 52-wk
$19.89
Mababa nang 52-wk
$12.99
EPS
-$0.33
Beta
-0.06
Mga natitirang share
3.20B
Bilang ng mga empleyado
47K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
ad-hoc-news.de
·
11 oras ang nakalipas
Takeda schedules October 29 results call for Takeda stock
TradingView
·
16 oras ang nakalipas
Takeda Pharmaceutical Company Limited Stock 12‑Month Price Target Raised to $20.74, Implies 9% Upside
Business Wire
·
19 oras ang nakalipas
Takeda’s ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 1
Stock Traders Daily
·
1 araw ang nakalipas
Trading the Move, Not the Narrative: (TAK) Edition
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Tungkol sa Takeda Pharmaceutical Co Ltd
CEOChristophe Weber | Christophe Weber
Mga Empleyado47K
ItinatagHun 12, 1781
Headquarters-
Sektor-
Websitetakeda.com